R. Scott Wright, MD - Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/01/66/72/01667244-d5eb-2aca-7116-adb6e2ae55fc/mza_7170852177260814164.jpg/600x600bb.jpg

PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast

PVI, PeerView Institute for Medical Education

48 episodes

1 week ago

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

All content for PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast is the property of PVI, PeerView Institute for Medical Education and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

R. Scott Wright, MD - Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management

PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast

30 minutes 4 seconds

1 year ago

R. Scott Wright, MD - Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GVK865. CME credit will be available until February 13, 2025.

Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.

Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Disclosures
R. Scott Wright, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Novo Nordisk Inc.

CME Reviewer

Ramil Goel
Assistant Professor of Medicine
Division of Cardiovascular Medicine
Electrophysiology Section
University of Florida College of Medicine
Gainesville, Florida

Ramil Goel, MD, FHRS, has no relevant financial relationships to disclose.